Drug Reaction with eosinophilia and systemic symptoms with alopecia universalis and vitiligo
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2021.179965Palabras clave:
Drug hypersensitivity, Eosinophilia, Anticonvulsants, Drug eruptionsResumen
Drug reactions with eosinophilia and systemic symptoms (DRESS) are rare and potentially fatal adverse hypersensitivity reaction to some drugs, especially anticonvulsants. The syndrome affects not only the skin but also other organs, especially the liver. The incidence can vary from 1 to 5 cases per 10.000 patients exposed to anticonvulsants.
The recognition of the syndrome is of fundamental importance since the mortality rate is between 10 and 40%. Once the diagnosis is established, the triggering drug must be identified and discontinued. Corticosteroids are usually associated with therapy. Autoimmune sequelae have been reported, including vitiligo and rarely alopecia. Alopecia universalis is a variant of alopecia areata, characterized by hair loss throughout the body. We report a case of DRESS, associated with two autoimmune dermatological diseases: alopecia universalis and vitiligo.
Descargas
Referencias
Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019;68(3):301-308. doi:10.1016/j.alit.2019.03.006
Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019;68(3):301-308. doi:10.1016/j.alit.2019.03.006
Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609-611. doi:10.1111/j.1365-2133.2006.07704.x
Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017;390(10106):1996-2011. doi:10.1016/S0140-6736(16)30378-6
Kano Y, Tohyama M, Aihara M, et al. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). J Dermatol. 2015;42(3):276-282. doi:10.1111/1346-8138.12770.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2021 Ives Alexandre Yutani Koseki, Débora Sarzi Sartori, Isabelle Maffei Guarenti, Fábio Yutani Koseki, Amanda Dagostim Gietner, Simoni Euzébio Nunes
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.